NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis → FW: 234x Gain (From Weiss Ratings) (Ad) Free NRC Stock Alerts $34.87 -0.10 (-0.29%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$34.47▼$35.2050-Day Range$32.87▼$40.9552-Week Range$32.08▼$47.25Volume55,554 shsAverage Volume47,435 shsMarket Capitalization$831.65 millionP/E Ratio27.90Dividend Yield1.38%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get National Research alerts: Email Address National Research MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.36% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.28Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.84 out of 5 starsBusiness Services Sector1663rd out of 1,878 stocksCommercial Physical Research Industry61st out of 66 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for National Research. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.36% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in National Research has recently increased by 11.95%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldNational Research pays a meaningful dividend of 1.37%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 38.40%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NRC. Previous Next 1.8 News and Social Media Coverage News SentimentNational Research has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.40 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 7 news articles for National Research this week, compared to 3 articles on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Research insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 27.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.47.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 27.90, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 30.69.Price to Book Value per Share RatioNational Research has a P/B Ratio of 17.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. About National Research Stock (NASDAQ:NRC)National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.Read More NRC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NRC Stock News HeadlinesMay 2, 2024 | msn.comWaiting for Eritrean Human Traffickers' Trials in the NetherlandsMay 1, 2024 | ca.news.yahoo.comAlberta Innovates helping businesses succeedMay 4, 2024 | Paradigm Press (Ad)Never use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...April 30, 2024 | msn.comWho is Jessica Gunning? Actress who plays Martha Scott in Netflix drama Baby ReindeerApril 30, 2024 | finanznachrichten.deNanalysis Scientific Corp.: Nanalysis Announces Fourth Quarter and Full Year 2023 ResultsApril 29, 2024 | msn.comNorthern Ireland city twins with Korea's administration capital to develop research and innovation opportunitiesApril 29, 2024 | msn.comRussians recruit Belarusian youth to assemble UAVsApril 23, 2024 | yahoo.comCan Aging U.S. Nuclear Power Plants Withstand More Extreme Weather?May 4, 2024 | Paradigm Press (Ad)Never use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...April 22, 2024 | msn.comCAA may potentially violate India's Constitution, claims US Congress reportApril 22, 2024 | msn.comCAA provisions may violate Indian Constitution: US congressional reportApril 18, 2024 | businesswire.comNational Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the InternetApril 17, 2024 | msn.comNarendra Modi Is Preparing New Attacks on Democratic RightsApril 16, 2024 | msn.comProvince to conduct rare earth minerals survey near Swift CurrentApril 16, 2024 | finance.yahoo.comSt. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney InjuryApril 11, 2024 | msn.comWill not accept CAA, NRC, Uniform Civil Code: MamataApril 8, 2024 | theglobeandmail.comSona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and DevelopmentApril 4, 2024 | finance.yahoo.comNanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit SubstancesApril 2, 2024 | businesswire.comVeteran Patient Experience Executive Jennifer Baron Joins NRC Health as Its First Chief Experience OfficerMarch 30, 2024 | msn.comCAA is a classic case of dead on arrival. It’ll be forgotten after 2024 electionsMarch 30, 2024 | msn.comGame of Thrones star Emilia Clarke's mum backs National Rehabilitation CentreMarch 28, 2024 | msn.comCongress ramps pressure to speed up nuclear power developmentMarch 27, 2024 | msn.comCongress under pressure to speed up nuclear power developmentMarch 27, 2024 | msn.comAerial footage shows scale of progress made on National Rehabilitation CentreMarch 21, 2024 | finance.yahoo.comInvestors in National Research (NASDAQ:NRC) have unfortunately lost 5.2% over the last three yearsMarch 18, 2024 | msn.comUS Senator expresses concern over notification of CAA rulesMarch 14, 2024 | markets.businessinsider.comThe U.S. Is Betting Big on Small Nuclear ReactorsSee More Headlines Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Ex-Dividend for 4/15 Dividend3/27/2024Dividend Payable4/15/2024Today5/04/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:NRC CUSIPN/A CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees435Year Founded1981Profitability EPS (Most Recent Fiscal Year)$1.25 Trailing P/E Ratio27.90 Forward P/E RatioN/A P/E GrowthN/ANet Income$30.97 million Net Margins20.84% Pretax Margin26.90% Return on Equity47.79% Return on Assets24.27% Debt Debt-to-Equity Ratio0.60 Current Ratio0.67 Quick Ratio0.67 Sales & Book Value Annual Sales$148.58 million Price / Sales5.60 Cash Flow$1.52 per share Price / Cash Flow22.97 Book Value$2.02 per share Price / Book17.26Miscellaneous Outstanding Shares23,850,000Free Float23,377,000Market Cap$831.65 million OptionableOptionable Beta0.45 Social Links These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Michael D. Hays (Age 69)Founder, CEO, President & Director Comp: $131.11kMs. Helen L. Hrdy (Age 59)Chief Customer Officer Comp: $291.51kMr. Christophe Louvion (Age 51)Chief Product & Technology Officer Mr. Andy Monnich (Age 48)Chief Corporate Development Officer Mr. Jon BoumsteinChief Delivery OfficerDr. Gregory Makoul M.S.Ph.D., Chief Transformation OfficerMr. Jason Hahn (Age 52)Chief Revenue Officer Ms. Linda StacySecretaryMegan CharkoSenior Manager of Content MarketingMore ExecutivesKey CompetitorsSimulations PlusNASDAQ:SLPDefinitive HealthcareNASDAQ:DHEnliven TherapeuticsNASDAQ:ELVNTango TherapeuticsNASDAQ:TNGX89bioNASDAQ:ETNBView All CompetitorsInsiders & InstitutionsDaiwa Securities Group Inc.Bought 4,350 shares on 5/2/2024Ownership: 0.162%BNP Paribas Financial MarketsSold 3,986 shares on 5/1/2024Ownership: 0.031%Precision Wealth Strategies LLCBought 413 shares on 5/1/2024Ownership: 0.024%Norden Group LLCBought 9,250 shares on 4/30/2024Ownership: 0.039%Benjamin F. Edwards & Company Inc.Bought 1,015 shares on 4/29/2024Ownership: 0.005%View All Insider TransactionsView All Institutional Transactions NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed in 2024? National Research's stock was trading at $39.56 at the beginning of the year. Since then, NRC stock has decreased by 11.9% and is now trading at $34.87. View the best growth stocks for 2024 here. When is National Research's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our NRC earnings forecast. How can I listen to National Research's earnings call? National Research will be holding an earnings conference call on Wednesday, May 8th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 866-813-9403 with passcode "619474". How were National Research's earnings last quarter? National Research Co. (NASDAQ:NRC) posted its quarterly earnings results on Tuesday, February, 13th. The company reported $0.36 earnings per share for the quarter. The company earned $38 million during the quarter. National Research had a net margin of 20.84% and a trailing twelve-month return on equity of 47.79%. How often does National Research pay dividends? What is the dividend yield for National Research? National Research declared a quarterly dividend on Tuesday, February 13th. Stockholders of record on Friday, March 29th will be paid a dividend of $0.12 per share on Monday, April 15th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date is Wednesday, March 27th. Read our dividend analysis for NRC. Is National Research a good dividend stock? National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.37%. The dividend payout ratio is 38.40%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for NRC. What is Michael D. Hays' approval rating as National Research's CEO? 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD). Who are National Research's major shareholders? National Research's stock is owned by many different institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.29%), QV Investors Inc. (1.44%), Norden Group LLC (0.55%), Daiwa Securities Group Inc. (0.16%), Cardinal Capital Management (0.11%) and Azzad Asset Management Inc. ADV (0.11%). Insiders that own company stock include Amandla Mk Trust, Jona S Raasch and Kevin R Karas. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does National Research have any subsidiaries? The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.Read More This page (NASDAQ:NRC) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.